Skip to content

FS-LASIK Versus TransPRK for Mixed Astigmatism

Comparative Study of Femtosecond Laser-assisted LASIK and Single-step Transepithelial Photorefractive Keratectomy for Correction of Mixed Astigmatism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07481227
Enrollment
39
Registered
2026-03-18
Start date
2019-06-15
Completion date
2025-06-15
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed Astigmatism

Keywords

Astigmatism, Mixed astigmatism, FS-LASIK, TransPRK

Brief summary

Mixed astigmatism is a type of refractive error in which the two principal steep and flat meridians focus the light in front and behind the retina, respectively.1 Laser vision correction (LVC) for mixed astigmatism is challenging as it involves a bitoric ablative pattern to flatten the steepest meridian and steepen the flattest one. The aim of the current study was to compare the visual and refractive outcomes of FS-LASIK versus single-step TransPRK for treatment of patients with mixed astigmatism.

Interventions

PROCEDUREFemtosecond laser-assisted LASIK

Patients in the FS-LASIK group underwent flap creation using the femtosecond laser WaveLight FS200® (Alcon lab, TX, USA). After flap creation, wave-front optimized stromal ablation was performed with WaveLight EX-500 (WaveLight®; Alcon Laboratories, Fort Worth, TX, USA) for mixed astigmatism correction.

Patients in the single-step TransPRK group underwent StreamLight® PRK in WaveLight EX-500 Excimer laser (WaveLight®; Alcon Laboratories, Fort Worth, TX, USA). In a single step, epithelial ablation (based on epithelial mapping) followed by stromal ablation for mixed astigmatism correction, were accomplished.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Mixed astigmatism (Plus sphere up to +4 diopters D and a minus cylinder up to -6 D). * Stable refraction. * Clear cornea. * Normal corneal tomography.

Exclusion criteria

* Corrected distance visual acuity worse than 20/32 Snellen's acuity. * Difference between manifest and cycloplegic refraction ≥ 1 D. * Previous corneal or ocular surgeries, other ocular diseases. * Systemic diseases including diabetes mellitus and autoimmune diseases.

Design outcomes

Primary

MeasureTime frameDescription
Uncorrected distance visual acuity (UDVA)24 monthsVisual acuity measurement using Snellen's Acuity Chart converted to logMAR notation.
Corrected distance visual acuity (CDVA)24 monthsCorrected visual acuity measurement using Snellen's Acuity Chart and converted to logMAR notation.
Postoperative refraction24 monthsManifest sphere and cylinder measured by Topcon Auto-Keratorefractometer

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026